Multi-Omics Integration in Personalized Medicine: Advancing Laboratory Diagnostics and Precision Therapeutics in the Era of Individualized Healthcare

Personalized medicine is revolutionizing healthcare by shifting from a one-size-fits-all model to a tailored approach that considers individual genetic, molecular, environmental, and lifestyle factors. This review comprehensively explores the role of personalized medicine in laboratory diagnostics and patient management through the lens of emerging omics technologies such as genomics, transcriptomics, proteomics, metabolomics, and pharmacogenomics. Each omics domain offers unique insights into disease mechanisms, drug response, and biomarker discovery, enabling more accurate diagnoses, targeted therapies, and improved treatment outcomes. While genomics and pharmacogenomics focus on the genetic basis of disease and therapeutic response, transcriptomics and proteomics bridge the functional gap between genotype and phenotype, revealing dynamic changes at the RNA and protein levels. Metabolomics adds another layer of complexity by capturing small-molecule metabolites that reflect cellular physiology in real time. Despite the promise of personalized medicine, its clinical implementation is hindered by technical limitations, high costs, data integration challenges, and concerns over reproducibility and data privacy. Moreover, optimizing transcriptomic study design, especially the balance between sequencing depth and biological replication, remains crucial for generating robust, reproducible data. The integration of multi-omics data holds the potential to drive breakthroughs in diagnosis and therapy, particularly in oncology, rare diseases, and complex disorders. This article highlights the critical role of personalized medicine in laboratory practice and advocates for continued investment in multi-omics technologies and data infrastructure to advance precision healthcare. Keywords: Personalized medicine, Multi-omics, Pharmacogenomics, Metabolomics, Transcriptomics